Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2010
03/18/2010US20100068268 Starch-based microparticles for the release of agents disposed therein
03/18/2010US20100068261 Methods and compositions for the production of monoclonal antibodies
03/18/2010US20100068255 liposomes comprising humanized Fab fragment of monoclonal antibody that binds cell surface markers, amphipathic vesicle-forming lipid and polyethylene glycol derivatized lipid, capable of inhibiting growth and proliferation of target cells; HER growth factor receptors
03/18/2010US20100068254 Modifying a medicament availability state of a final dosage form
03/18/2010US20100068240 Implantable nerve regeneration conduit
03/18/2010US20100068222 Hapten-carrier conjugates for use in drug abuse therapy and methods for preparation of same
03/18/2010US20100068170 Local delivery of water-soluble or water-insoluble therapeutic agents to the surface of body lumens
03/18/2010US20100068169 Monolithic drug delivery system
03/18/2010US20100068160 Cosmetic and dermatological formulations including phenoxyalkyl esters
03/18/2010CA2773755A1 Heparosan polymers and methods of making and using same for the enhancement of therapeutics
03/18/2010CA2749941A1 Ibuprofen for topical administration
03/18/2010CA2737247A1 Starch-based microparticles for the release of agents disposed therein
03/18/2010CA2736812A1 A polysaccharide capsule enclosing a fatty acid oil-containing emulsion
03/18/2010CA2736500A1 Local delivery of water-soluble or water-insoluble therapeutic agents to the surface body lumens
03/18/2010CA2734381A1 Improvements in the absorption of therapeutic agents across mucosal membranes or the skin
03/18/2010CA2734275A1 Compositions and methods for the prevention of oxidative degradation of proteins
03/18/2010CA2726726A1 Ibuprofen for topical administration
03/17/2010EP2163643A1 Soluble hyaluronidase glycoprotein (sHASEGP), process for preparing the same, uses and pharmaceutical compositions comprising thereof
03/17/2010EP2163261A1 Cold storage of PEG modified platelets
03/17/2010EP2163249A1 Infusion solution for peripheral intravenous administration
03/17/2010EP2162156A2 Immunocytokines for cancer treatment in combination with chemotherapeutic agents
03/17/2010EP2162155A2 Hydrogel materials
03/17/2010EP2162154A1 Colored esmolol concentrate
03/17/2010EP2162153A1 Dietary supplements for promotion of growth, repair, and maintenance of bone and joints
03/17/2010EP2162141A1 Composition for treating ischemic limb disease comprising stem cells derived from adipose tissue
03/17/2010EP2162128A1 Sesquiterpene formulations, kits and methods of use thereof
03/17/2010EP2162122A1 Compositions for prevention or treatment of anorexia-cachexia syndrome and uses thereof
03/17/2010EP2162120A2 Nanoparticles comprising a non-ionizable cellulosic polymer and an amphiphilic non-ionizable block copolymer
03/17/2010EP2162116A2 Vehicle in the form of a water-in-oil emulsion in particular for ophthalmic or dermocosmetic use
03/17/2010EP1807068B1 Composition comprising acetaminophen, caffeine and aspirin together with an alkiline agent fr enhanced absorption
03/17/2010EP1663177B1 Topical preparations comprising a hydrophilic carrier and a silicone matrix
03/17/2010EP1335689B1 Loratadine transdermal administration system and use thereof
03/17/2010EP1315502B1 Method for treating erectile dysfunction and increasing libido in men
03/17/2010EP1250166B1 Delivery systems for treatment of restenosis and anastomotic intimal hyperplasia
03/17/2010CN101675158A Cancerous disease modifying antibodies
03/17/2010CN101674853A Amino acid lipids and uses thereof
03/17/2010CN101674852A Multi-functional polyglutamate drug carriers
03/17/2010CN101674851A Method for producing storage-stable solutions from pelargonium extracts
03/17/2010CN101674850A Dry extracts of pelargonium sidoides and pelargonium reniforme
03/17/2010CN101674810A Targeting agent for cancer cell or cancer-associated fibroblast
03/17/2010CN101674809A Self-precipitating pharmaceutical formulations for the modified release of active principle
03/17/2010CN101674807A Compositions for reducing, ameliorating, treating, or preventing condition of dry eye and methods of making and using same
03/17/2010CN101674805A High concentration factor vii polypeptide formulations comprising an aromatic preservative and an antioxidant
03/17/2010CN101674804A ophthalmic oil-in-water emulsions containing prostaglandins
03/17/2010CN101674803A Concentrate esmolol
03/17/2010CN101671554A Silica-coated fluorescent magnetic nanoparticle, preparation method and application
03/17/2010CN101671407A Liquid dispersion polymer compositions, their preparation and their use
03/17/2010CN101671397A Anti-EGFR single-chain antibody fusion Gelonin recombination immunotoxin, preparation method and usage thereof
03/17/2010CN101671335A Cytotoxins, prodrugs, linkers and stabilizers useful therefor
03/17/2010CN101671260A Method for preparing O-desmethyl-venlafaxine
03/17/2010CN101671248A Long effective curcumin derivative and preparation method thereof
03/17/2010CN101671032A Calcium silicate multi-level nano-structure mesoporous microsphere and preparation method thereof
03/17/2010CN101670116A Forebody drug with conjugate linoleic acid connected with antitumor drug and preparation method thereof
03/17/2010CN101670115A Compound of heparanase and heat shock protein, preparation method and applications thereof
03/17/2010CN101670114A Compound of survivin and heat shock protein, preparation method and applications thereof
03/17/2010CN101670113A Beta cyclodextrin clathrate of cantharidin and Chinese blister beetle extracts and method for preparing same
03/17/2010CN101670112A Stable albumins lipid medicine carrying system and preparation method thereof
03/17/2010CN101670111A Thioctic acid-glucan conjugate, preparation method and usage thereof
03/17/2010CN101670110A Hydrogel controlled by hydrogen bond and pi-pi accumulation biswitch and preparation and application thereof
03/17/2010CN101670109A Medicament doped organic xerogel medicament slow release carrier material and preparation method thereof
03/17/2010CN101670108A Medicine carrying system based on nano graphene oxide
03/17/2010CN101670107A Multifunctional nuclear shell structure drug carrier material and preparation method thereof
03/17/2010CN101670103A Compound panax ginseng total saponin and levamisole nano emulsion adjuvant and preparation method thereof
03/17/2010CN101670095A Pharmaceutical composition for treating embolism and preparation method thereof
03/17/2010CN101670094A Compound gentamycin sulfate soluble powder and preparation method thereof
03/17/2010CN101670092A Method for preparing liver cell growth promoter freeze-drying powder injection for injecting
03/17/2010CN101670068A Medicament for treating gonarthromeningitis and preparation technology thereof
03/17/2010CN101670045A Externally applied traditional Chinese medicine for treating cervical carcinoma
03/17/2010CN101670017A Medicine combination for tonifying blood and preparation method thereof
03/17/2010CN101669998A Corydalis saxicola pill and preparation method thereof
03/17/2010CN101669997A Transdermal administration defervescence preparation containing eugenol
03/17/2010CN101669996A Method for preparing vision-health buccal tablet
03/17/2010CN101669986A Compound gel preparation containing sophora alopecuroide oil
03/17/2010CN101669982A Radix isatidis dispersible tablet and preparation technology thereof
03/17/2010CN101669978A Buffer-contained Chinese traditional medicine panax notoginseng saponins
03/17/2010CN101669975A Method for producing rubber matrix Chinese medicine plaster based on Mooney viscosity
03/17/2010CN101669974A Traditional Chinese medicine prescription granule preparation by melted extrusion method
03/17/2010CN101669968A Particle blood platelet dry powder preparation and preparation method thereof and application thereof
03/17/2010CN101669961A Method for producing Chinese-western compound preparation for preventing and treating animal synthetic respiratory diseases
03/17/2010CN101669956A Composition of cefoxitin acid
03/17/2010CN101669953A Methionine vitamin B1 pharmaceutical composition for injection
03/17/2010CN101669950A Application of aloperin in preparation of drug for treating ulcerative colitis
03/17/2010CN101669943A Oral solid preparation of faropenem and salt derivative thereof
03/17/2010CN101669942A Insoluble pharmaceutical composition
03/17/2010CN101669937A Composition of ginkgolide and ganglioside and preparation method thereof
03/17/2010CN101669932A Application of long effective curcumin derivative in preparing anti-depression drug
03/17/2010CN101669931A Application of long effective curcumin derivative in preparing anti-tumor disease drug
03/17/2010CN101669929A Preparation method and application of ibuprofen liquid preparation
03/17/2010CN101669928A Slow-release composition containing antidepressant
03/17/2010CN101669926A Liquid preparation for dosing nasal cavities and method for making the same
03/17/2010CN101669924A 贴剂和贴剂制剂 Patch and patch preparation
03/17/2010CN101669923A Adhesive patch for protecting and treating viral cutaneous lesions
03/17/2010CN101669922A Medicament carrying film capable of being absorbed by oral cavity and preparation method thereof
03/17/2010CN101669917A Scopolamine hydrobromide orally disintegrating microencapsule tablets based on NIMS system
03/17/2010CN101669916A Method for preparing nifedipine freeze-dried powder injection
03/17/2010CN101669915A Oridonin dry emulsion and preparation method thereof
03/17/2010CN101669914A Pharmaceutical dosage forms for controlled release producing at least a timed pulse
03/17/2010CN101669913A Levocetirizine dihydrochloride granule and preparation and detection methods thereof
03/17/2010CN101669912A Slow-release composition containing tamsulosin and preparation thereof
03/17/2010CN101669911A Dicazuril soluble powder and preparation method thereof